Doxorubicin loaded magneto-niosomes for targeted drug delivery.
about
Mechanisms Underlying Cytotoxicity Induced by Engineered Nanomaterials: A Review of In Vitro StudiesTrans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.Beta Hairpin Peptide Hydrogels as an Injectable Solid Vehicle for Neurotrophic Growth Factor Delivery.Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations.Nonionic surfactant vesicles for delivery of RNAi therapeutics.Sustained release of active chemotherapeutics from injectable-solid β-hairpin peptide hydrogel.Cationic niosomes an effective gene carrier composed of novel spermine-derivative cationic lipids: effect of central core structures.Plasma stable, pH-sensitive non-ionic surfactant vesicles simultaneously enhance antiproliferative effect and selectivity of Sirolimus.Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.Novel in situ gelling ocular inserts for voriconazole-loaded niosomes: design, in vitro characterisation and in vivo evaluation of the ocular irritation and drug pharmacokinetics.Drug compartmentalization as strategy to improve the physico-chemical properties of diclofenac sodium loaded niosomes for topical applications.Microniosomes for concurrent doxorubicin and iron oxide nanoparticles loading; preparation, characterization and cytotoxicity studies.Creatinine-based non-phospholipid vesicular carrier for improved oral bioavailability of Azithromycin.Niosomes as Nanoparticular Drug Carriers: Fundamentals and Recent Applications
P2860
Q29248759-812AE1F5-5D36-4C5E-9AA7-1CE1A40C60FCQ36003406-75B3EEEF-0A3E-40E9-8F05-6674DB39D98DQ36919148-03F5F2F1-734F-4502-BDDA-9E36F3F7C218Q38155210-BBE43F9C-1C6E-45CA-9CB9-24DDCF1BF05FQ38571809-7962344B-C8FE-465D-98AE-16D4881A77EBQ38791686-5A475F27-FAE5-4744-86CF-64FAD73320CEQ38808635-11380869-ED13-41E4-A567-96BD4C90F003Q39058091-236B1706-AE37-47D8-887B-E074574B729BQ41987657-FFF61C77-A12D-40CD-AB94-670DCABE36DBQ46844328-FF614B26-004D-48F7-97D9-2FEE31095138Q51062773-E1865340-E6CC-4F2A-B682-A30345F81469Q53380228-8DE0C7EF-9DA9-454D-8EDB-27743F422095Q53528770-C5E209C5-84FF-4B87-9C37-60FEAE7118ADQ59128542-FF8B61E5-0FD1-4FFA-A148-F56A4C591D65
P2860
Doxorubicin loaded magneto-niosomes for targeted drug delivery.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Doxorubicin loaded magneto-niosomes for targeted drug delivery.
@en
Doxorubicin loaded magneto-niosomes for targeted drug delivery.
@nl
type
label
Doxorubicin loaded magneto-niosomes for targeted drug delivery.
@en
Doxorubicin loaded magneto-niosomes for targeted drug delivery.
@nl
prefLabel
Doxorubicin loaded magneto-niosomes for targeted drug delivery.
@en
Doxorubicin loaded magneto-niosomes for targeted drug delivery.
@nl
P2093
P50
P1476
Doxorubicin loaded magneto-niosomes for targeted drug delivery
@en
P2093
Marco Vivacqua
Maria Cristina Caroleo
Valentina Carito
P304
P356
10.1016/J.COLSURFB.2012.09.019
P577
2012-09-18T00:00:00Z